Widaplik is indicated for the treatment of hypertension, including as initial treatment, to lower blood pressure.

Telmisartan, amlodipine; 40mg/5mg, 40mg/10mg, 80mg/5mg, 80mg/10mg; tabs. Take once daily. Initial therapy: 40/5mg or 80/5mg; may titrate at 2-week intervals to max 80/10mg. Add-on therapy ...

In a statement from Teva posted by the Food and Drug Administration, the recall affects all lots of combination tablets featuring the drugs amlodipine and valsartan and another combo drug ...

Sold as Widaplik, it is the first and only single pill to combine three previously FDA-approved drugs – telmisartan, amlodipine, and indapamide – offering a triple-action approach for ...

Discover comprehensive details about Telmisartan and Amlodipine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.

GMRx2 contains telmisartan, amlodipine and indapamide in three dose strengths: triple quarter doses (10 mg, 1.25 mg and 0.625 mg, respectively), triple half doses (20 mg, 2.5 mg and 1.25 mg ...

Patients were advised to continue the medication and reach out to their doctor. A Food and Drug Administration recall of a heart medication due to a cancer-causing chemical now includes two blood ...

Review the side-effects of Telmisartan and Amlodipine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.

TEVA) announces the launch of the generic equivalent to Exforge® (amlodipine and valsartan) Tablets in four different strengths, in the United States. Exforge® (amlodipine and valsartan ...

Customers and patients with medical-related questions, information about an Adverse Event or other questions about the Teva products being recalled should contact Teva’s Medical Information by ...